Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (231-240 of 326) with videos related to

Pageof 33
Sort By:
Alimentary Pharmacology & Therapeutics|September 10, 2024
Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetesXianhua Mao, Ka-Shing Cheung, Jing-Tong Tan, et al.
Antiviral Therapy|February 5, 2008
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced diseaseMan-Fung Yuen, Wai-Kay Seto, Danny Hoi-Fan Chow, et al.
International Journal of Molecular Sciences|March 13, 2024
The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVacHo-Yu Ng, Yunshi Liao, Ruiqi Zhang, et al.
Gut|April 3, 2024
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort studyXianhua Mao, Ka Shing Cheung, Jing-Tong Tan, et al.
Vaccines|July 27, 2022
Association between Recent Usage of Antibiotics and Immunogenicity within Six Months after COVID-19 VaccinationKa-Shing Cheung, Lok-Ka Lam, Ruiqi Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2019
Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogueLung-Yi Mak, Chi-Ho Lee, Ka-Shing Cheung, et al.
The American Journal of Cardiology|January 1, 2016
Relation of Tricuspid Regurgitation to Liver Stiffness Measured by Transient Elastography in Patients With Left-Sided Cardiac Valve DiseaseYan Chen, Wai-Kay Seto, Lai-Ming Ho, et al.
Journal of the American Heart Association|July 15, 2018
Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid AnnuloplastyYan Chen, Ying-Xian Liu, Wai-Kay Seto, et al.
Clinical and Molecular Hepatology|May 12, 2026
Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohortJasmohan S Bajaj, Patrick S Kamath, Florence Wong, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trialKa Shing Cheung, Ho Yu Ng, Rex Wan Hin Hui, et al.
Pageof 33

Showing results (231-240 of 326) with videos related to

Sort By:
Pageof 33
Alimentary Pharmacology & Therapeutics|September 10, 2024
Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetesXianhua Mao, Ka-Shing Cheung, Jing-Tong Tan, et al.
Antiviral Therapy|February 5, 2008
Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced diseaseMan-Fung Yuen, Wai-Kay Seto, Danny Hoi-Fan Chow, et al.
International Journal of Molecular Sciences|March 13, 2024
The Predictive Value of Gut Microbiota Composition for Sustained Immunogenicity following Two Doses of CoronaVacHo-Yu Ng, Yunshi Liao, Ruiqi Zhang, et al.
Gut|April 3, 2024
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort studyXianhua Mao, Ka Shing Cheung, Jing-Tong Tan, et al.
Vaccines|July 27, 2022
Association between Recent Usage of Antibiotics and Immunogenicity within Six Months after COVID-19 VaccinationKa-Shing Cheung, Lok-Ka Lam, Ruiqi Zhang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2019
Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long-term nucleoside analogueLung-Yi Mak, Chi-Ho Lee, Ka-Shing Cheung, et al.
The American Journal of Cardiology|January 1, 2016
Relation of Tricuspid Regurgitation to Liver Stiffness Measured by Transient Elastography in Patients With Left-Sided Cardiac Valve DiseaseYan Chen, Wai-Kay Seto, Lai-Ming Ho, et al.
Journal of the American Heart Association|July 15, 2018
Prognostic Value of Hepatorenal Function By Modified Model for End-stage Liver Disease (MELD) Score in Patients Undergoing Tricuspid AnnuloplastyYan Chen, Ying-Xian Liu, Wai-Kay Seto, et al.
Clinical and Molecular Hepatology|May 12, 2026
Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohortJasmohan S Bajaj, Patrick S Kamath, Florence Wong, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trialKa Shing Cheung, Ho Yu Ng, Rex Wan Hin Hui, et al.
Pageof 33